Table 1: Comparison of demographic and clinical factors
between the intervention (convalescent plasma) group and the control
(dexamethasone) group.
|
Variable |
Control group (N = 50) |
Convalescent plasma (N = 28) |
p-value |
|
Demographic characteristics |
|
|
|
|
Age in years mean (sd) |
52.5 (14.5) |
53.8 (14.3) |
0.71 |
|
Male sex n (%) |
30 (60.0) |
13 (48.1) |
0.32 |
|
Body mass index, median [IQR] |
30 [28 – 32] |
32 [29 – 35] |
0.19 |
|
Co-morbidities n (%) |
|
|
|
|
Diabetes Mellitus |
15 (30.6) |
12 (44.4) |
0.23 |
|
Hypertension |
23 (47.9) |
15 (55.6) |
0.53 |
|
Stroke |
1 (2.1) |
1 (3.7) |
1.00 |
|
Renal disease |
6 (12.5) |
6 (22.2) |
0.33 |
|
Ischaemic heart disease |
3 (6.4) |
4 (14.8) |
0.25 |
|
Drug usage n (%) |
|
|
|
|
Oral diabetics |
17 (35.4) |
10 (38.5) |
0.80 |
|
Insulin |
3 (6.4) |
3 (11.1) |
0.66 |
|
ACE-inhibitors |
8 (17.0) |
7 (25.9) |
0.36 |
|
Angiotensin receptor blockers |
3 (6.4) |
1 (3.7) |
0.62 |
|
Presence of symptoms n (%) |
|
|
|
|
Fever |
39 (78.0) |
22 (81.5) |
0.72 |
|
Dyspnea |
44 (88.0) |
24 (88.9) |
1.00 |
|
Cough |
25 (50.0) |
18 (69.2) |
0.11 |
|
Sputum |
4 (8.2) |
2 (7.4) |
0.91 |
|
Loss of taste |
7 (14.3) |
6 (22.2) |
0.53 |
|
Anosmia |
7 (14.3) |
5 (18.5) |
0.75 |
|
Diarrhea |
10 (20.4) |
3 (11.1) |
0.36 |
|
Vomiting |
4 (8.3) |
2 (7.4) |
1.00 |
|
Acute renal failure |
3 (6.3) |
6 (23.1) |
0.06 |
|
Covid Classification n (%) |
|
|
0.44 |
|
Severe |
33 (66.0) |
16 (57.1) |
|
|
Life-threatening |
17 (34.0) |
12 (42.9) |
|
ACE:
Angiotensine Converting Enzyme; IQR: Interquartile Range; Sd: Standard
Deviation.